DELTA_2B | R Documentation |
Kaplan-Meier digitized data from DELTA, figure 2B (PMID 24841974). A reported sample size of 301 for a primary endpoint of PFS in lung cancer.
DELTA_2B
A data frame of 301 observations and 3 variables:
time | event time (in months) | |
event | OS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (d1, erlotinib) | |
Kawaguchi T, Ando M, Asami K, et al. Randomized phase III trial of erlotinib versus docetaxel as second- or third-line therapy in patients with advanced non-small-cell lung cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA). J Clin Oncol 2014; 32: 1902–8.
summary(DELTA_2B)
kmplot(DELTA_2B)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.